Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 28,633 | 28,731 | 27,686 | 23,046 | 20,263 |
| Cost of Goods | 13,616 | 12,798 | 11,542 | 10,102 | 10,149 |
| Gross Profit | 15,017 | 15,933 | 16,144 | 12,944 | 10,114 |
| Operating Expenses | 12,190 | 12,661 | 13,815 | 12,911 | 10,815 |
| Operating Income | 2,827 | 3,272 | 2,329 | 33 | -701 |
| Interest Expense | 3,612 | 3,552 | 3,293 | 3,149 | 3,107 |
| Other Income | 797 | -680 | -1,577 | 1,564 | 199 |
| Pre-tax Income | 12 | -960 | -2,541 | -1,552 | -3,609 |
| Income Tax | -6,844 | 547 | 189 | -154 | 1,678 |
| Net Income Continuous | 6,856 | -1,507 | -2,730 | -1,398 | -5,287 |
| Net Income | $6,856 | $-1,507 | $-2,730 | $-1,398 | $-5,287 |
| EPS Basic Total Ops | 0.34 | -0.07 | -0.14 | -0.07 | -0.27 |
| EPS Basic Continuous Ops | 0.34 | -0.07 | -0.14 | -0.07 | -0.27 |
| EPS Diluted Total Ops | 0.34 | -0.07 | -0.14 | -0.07 | -0.27 |
| EPS Diluted Continuous Ops | 0.34 | -0.07 | -0.14 | -0.07 | -0.27 |
| EBITDA(a) | $5,111 | $4,107 | $2,289 | $3,139 | $1,015 |